Related Experiment Video
Updated: Mar 26, 2026

08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.8K
Skin tumor immunity: Site does matter for antigen presentation by DCs
Jason Waithman1, Thomas Gebhardt2, Sammy Bedoui2
1Telethon Kids Institute, University of Western Australia, Subiaco, Australia.
European Journal of Immunology
|February 5, 2016
Summary
Effective anti-tumor immunity relies on dendritic cells (DCs) migrating to lymph nodes. DCs present tumor antigens more efficiently when they encounter them in the skin versus subcutaneous tissues.
Area of Science:
- Immunology
- Cancer Immunology
- Cellular Immunology
Background:
- The immune system can recognize and eliminate tumors, but the precise mechanisms are not fully elucidated.
- Understanding these mechanisms is crucial for developing effective cancer immunotherapies.
Purpose of the Study:
- To investigate the role of dendritic cell (DC) migration in anti-tumor immunity.
- To determine how the location of tumor antigen encounter influences DC-mediated antigen presentation.
Main Methods:
- The study by Joncker et al. examined the mobilization of tumor antigen-bearing dendritic cells (DCs) from peripheral tissues to lymph nodes.
- Investigated the efficiency of DC antigen presentation in different tissue environments (skin vs. subcutaneous).
Main Results:
- Timely migration of tumor antigen-bearing DCs to lymph nodes is essential for robust anti-tumor T-cell responses.
- Dendritic cells present tumor antigens more effectively when initially encountered in the skin compared to subcutaneous tissues.
Conclusions:
- Efficient anti-tumor immunity depends on the coordinated migration of antigen-presenting cells.
- The microenvironment of antigen encounter significantly impacts the efficacy of anti-tumor immune surveillance.
Related Concept Videos
Antigen Presenting Cells
4.2K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
4.2K
Antigens Involved in Adaptive Immunity
1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
T Cell Activation and Clonal Selection
17.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.2K
Antigen Processing Pathways
2.9K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.9K
Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K

